The Company now expects to report fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025. Management will host a live conference call, presentation ...

1,417,208 Series A Right Warrants Exercised at $1.13 Per Share, Providing $1.6 Million in Aggregate Gross Proceeds PRINCETON ... hospital (e.g. dialysis, ECMO, heart-lung machines).

On examination, the oral temperature was 36.2°C, the heart rate 89 beats per minute ... including hemorrhage and sepsis. 16 The solid tumors that most commonly infiltrate the bone marrow and ...

Estimated Pro-Forma December 31, 2024, Cash Balance and Q4 2024 Cash Burn As previously disclosed, the Company has raised a total of $7.85 million of aggregate gross proceeds in the first quarter ...

Detailed price information for Cytosorbents Cor (CTSO-Q) from The Globe and Mail including charting and trades.

Despite persistent racial and ethnic disparities in postoperative sepsis and septic shock risk, there is no evidence of inequity in regard to failure-to-rescue (FTR) rates for either condition. These ...

A new study led by the Center for Sepsis Epidemiology and Prevention Studies (SEPSIS) at the Harvard Pilgrim Health Care ...

Sepsis, a life-threatening condition caused by the body's dysregulated response to infection, remains a leading cause of ...

A new study raises critical questions about the effectiveness of the Centers for Medicare and Medicaid Services' (CMS) sepsis quality measure, known as the Severe Sepsis/Septic Shock Management Bundle ...

An Australian man lived for 100 days with an artificial titanium heart while he awaited a donor transplant, the longest period to date of someone with the technology. The patient, a man in his 40s ...